Assessing the Pharmacological and Pharmacogenomic Data of PD-1/PD-L1 Inhibitors to Enhance Cancer Immunotherapy Outcomes in the Clinical Setting.
Saved in:
| Title: | Assessing the Pharmacological and Pharmacogenomic Data of PD-1/PD-L1 Inhibitors to Enhance Cancer Immunotherapy Outcomes in the Clinical Setting. |
|---|---|
| Authors: | Zervanos, Damianos-Ioannis1 (AUTHOR), Galatou, Eleftheria2 (AUTHOR), Miliotou, Androulla N.1,2 (AUTHOR), Theodoroula, Nikoleta F.1,2 (AUTHOR), Grigoriadis, Nikolaos1 (AUTHOR), Vizirianakis, Ioannis S.1,2 (AUTHOR) |
| Source: | Future Pharmacology. Sep2025, Vol. 5 Issue 3, p43. 42p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
